Form 4 for BMY Bristol Myers Squibb
Accepted 2022-03-18 00:00:00 ET · period of report 2022-03-16 · accession 0000014272-22-000090 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2022-03-18 | 2022-03-16 | BMY | VESSEY RUPERT | EVP, Research, Early Dev | M - OptEx | $57.00 | +47.3K | 72.9K | +185% | +$2.70M |
| DM | 2022-03-18 | 2022-03-16 | BMY | VESSEY RUPERT | EVP, Research, Early Dev | S - Sale+OE | $69.25 | -74.6K | 46.3K | -62% | -$5.16M |
| DM | 2022-03-18 | 2022-03-16 | BMY | VESSEY RUPERT | EVP, Research, Early Dev | M - OptEx | $0.00 | -47.3K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock, $0.10 par value | 2022-03-16 | M | A | 21,288 | $66.35 | 67,596 | D | — | — | |
| 2 | Common | Common Stock, $0.10 par value | 2022-03-16 | S | D | 43,228 | $69.23 | 50,385 | D | — | — | (F2) 43,228 of the shares sold were to cover the exercise price and taxes in accordance with broker's procedures for sell-to-cover transactions. The price reported reflects the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $69.16 to $69.33, inclusive. The reporting person undertakes to provide the SEC staff, the issuer, or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price. |
| 3 | Common | Common Stock, $0.10 par value | 2022-03-16 | M | A | 12,233 | $54.29 | 85,123 | D | — | — | |
| 4 | Common | Common Stock, $0.10 par value | 2022-03-16 | M | A | 8,490 | $38.41 | 93,613 | D | — | — | |
| 5 | Common | Common Stock, $0.10 par value | 2022-03-16 | S | D | 31,331 | $69.27 | 46,308 | D | — | — | (F1) The price reported reflects the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $69.26 to $69.305, inclusive. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price. |
| 6 | Common | Common Stock, $0.10 par value | 2022-03-16 | M | A | 5,294 | $55.52 | 72,890 | D | — | — | |
| 7 | Derivative | Option (right to buy) | 2022-03-16 | M | D | 21,288 | $0.00 | 0 | D | $66.35 · — to 2027-05-01 | 21,288 Common Stock, $0.10 par value | (F4) All of the shares are currently exercisable. |
| 8 | Derivative | Option (right to buy) | 2022-03-16 | M | D | 8,490 | $0.00 | 8,491 | D | $38.41 · — to 2028-10-29 | 8,490 Common Stock, $0.10 par value | (F4) All of the shares are currently exercisable. |
| 9 | Derivative | Option (right to buy) | 2022-03-16 | M | D | 5,294 | $0.00 | 0 | D | $55.52 · — to 2028-01-29 | 5,294 Common Stock, $0.10 par value | (F4) All of the shares are currently exercisable. |
| 10 | Derivative | Option (right to buy) | 2022-03-16 | M | D | 12,233 | $0.00 | 0 | D | $54.29 · — to 2027-10-30 | 12,233 Common Stock, $0.10 par value | (F4) All of the shares are currently exercisable. |